TY  - GEN
AU  - Cruijsen,Marjan
AU  - Hobo,Willemijn
AU  - van der Velden,Walter J F M
AU  - Bremmers,Manita E J
AU  - Woestenenk,Rob
AU  - Bär,Brigitte
AU  - Falkenburg,J H Frederik
AU  - Kester,Michel
AU  - Schaap,Nicolaas P M
AU  - Jansen,Joop
AU  - Blijlevens,Nicole N M
AU  - Dolstra,Harry
AU  - Huls,Gerwin
TI  - Addition of 10-Day Decitabine to Fludarabine/Total Body Irradiation Conditioning is Feasible and Induces Tumor-Associated Antigen-Specific T Cell Responses
SN  - 1523-6536
PY  - 2018///0212
KW  - Adult
KW  - Aged
KW  - Antigens, Neoplasm
KW  - immunology
KW  - Antimetabolites, Antineoplastic
KW  - administration & dosage
KW  - Azacitidine
KW  - CD8-Positive T-Lymphocytes
KW  - drug effects
KW  - Decitabine
KW  - Female
KW  - Graft vs Host Disease
KW  - Hematopoietic Stem Cell Transplantation
KW  - adverse effects
KW  - Humans
KW  - Leukemia, Myeloid, Acute
KW  - mortality
KW  - Leukemia, Myelomonocytic, Chronic
KW  - Male
KW  - Middle Aged
KW  - Myelodysplastic Syndromes
KW  - Survival Analysis
KW  - Transplantation Conditioning
KW  - Transplantation, Homologous
KW  - Vidarabine
KW  - Whole-Body Irradiation
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1016/j.bbmt.2016.02.003
ER  -